empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]
RxNorm concept 1602115, branded drug (sbd). Prescribable name: Glyxambi 10 MG / 5 MG Oral Tablet.
- RxCUI
- 1602115
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1602115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Glyxambi (empagliflozin 10 MG / linagliptin 5 MG) Oral Tablet
Related concepts
- linagliptin 5 MG (SCDC, consists of)
- empagliflozin 10 MG (SCDC, consists of)
- empagliflozin 10 MG / linagliptin 5 MG [Glyxambi] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Glyxambi (BN, has ingredient)
- empagliflozin 10 MG / linagliptin 5 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1602115 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1602115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1602115. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.